Jammu, India

Subhash Chandra Taneja



Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 22(Granted Patents)


Location History:

  • Jammu, IN (1997 - 2007)
  • Jammu Tawi, IN (2013 - 2015)

Company Filing History:


Years Active: 1997-2015

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Celebrating Innovation: The Journey of Inventor Subhash Chandra Taneja

Introduction: Subhash Chandra Taneja, an innovative inventor based in Jammu, India, has made significant contributions to the field of pharmacology through his extensive research and development efforts. With a remarkable portfolio of 14 patents, Taneja is paving the way for advancements in medical treatments and enhancing the efficacy of drugs.

Latest Patents: Among Taneja's latest contributions are groundbreaking patents focused on improving the bioefficacy of anti-infective drugs and developing novel anticancer agents. One of his key inventions is titled "Aromatic amides as potentiators of bioefficacy of anti-infective drugs." This invention showcases the use of aromatic substituted pentadienoic acid amides in combination with specific amounts of aromatic amides to enhance the effect of anti-infective drugs. This combination has applications in treating infections with lower concentrations of anti-infectives, potentially reducing resistance in microorganisms.

Another significant patent is "Spiro derivatives of parthenin as novel anticancer agents." This invention introduces innovative spiro derivatives obtained through various cycloadditions, showing promising anticancer activity. The research indicates that these compounds exhibit varying levels of cytotoxicity, emphasizing the importance of the α,β-unsaturated ketonic moiety in maintaining high cytotoxicity levels against different cancer cell lines.

Career Highlights: Subhash Chandra Taneja is affiliated with the Council of Scientific & Industrial Research, where he conducts cutting-edge research. His work reflects a dedication to improving drug efficacy and minimizing adverse effects in treatments related to infectious diseases and cancer.

Collaborations: Throughout his career, Taneja has collaborated with esteemed colleagues such as Ghulam Nabi Qazi and Surrinder Koul. These partnerships have fostered an environment of innovation, enabling Taneja to further extend his research and patent portfolio.

Conclusion: Subhash Chandra Taneja stands as a notable figure in the realm of pharmaceutical innovation. His continuous efforts in developing novel compounds and enhancing drug efficacy reinforce the critical role that inventors play in advancing healthcare solutions. With 14 patents to his name, Taneja's work exemplifies the spirit of innovation that drives the scientific community forward.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…